Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
31,168,555
-
Share change
-
-349,934
-
Total reported value
-
$383,056,907
-
Put/Call ratio
-
403%
-
Price per share
-
$12.29
-
Number of holders
-
92
-
Value change
-
-$53,572,954
-
Number of buys
-
60
-
Number of sells
-
36
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2016
As of 30 Sep 2016,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,168,555 shares.
The largest 10 holders included
Flagship Ventures Management, Inc., FMR LLC, FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, Capital World Investors, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, D. E. Shaw & Co., Inc., Artal Group S.A., and BlackRock Institutional Trust Company, N.A..
This page lists
92
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.